Attached files

file filename
8-K - 8-K - WebMD Health Corp.d716070d8k.htm
EX-99.3 - EX-99.3 - WebMD Health Corp.d716070dex993.htm
EX-99.4 - EX-99.4 - WebMD Health Corp.d716070dex994.htm
EX-99.1 - EX-99.1 - WebMD Health Corp.d716070dex991.htm

Exhibit 99.2

WEBMD HEALTH CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data, unaudited)

 

     Three Months Ended
March 31,
 
     2014      2013  

Revenue

   $ 133,832       $ 112,762   

Cost of operations

     52,564         46,943   

Sales and marketing

     32,911         30,933   

General and administrative

     23,781         23,534   

Depreciation and amortization

     7,328         6,853   

Interest income

     15         21   

Interest expense

     6,172         5,832   
  

 

 

    

 

 

 

Income (loss) before income income tax provision

     11,091         (1,312

Income tax provision

     4,825         226   
  

 

 

    

 

 

 

Net income (loss)

   $ 6,266       $ (1,538
  

 

 

    

 

 

 

Net income (loss) per common share:

     

Basic

   $ 0.16       $ (0.03
  

 

 

    

 

 

 

Diluted

   $ 0.15       $ (0.03
  

 

 

    

 

 

 

Weighted-average shares outstanding used in computing income (loss) per common share:

     

Basic

     39,268         49,007   
  

 

 

    

 

 

 

Diluted

     41,852         49,007   
  

 

 

    

 

 

 


WEBMD HEALTH CORP.

CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION

(In thousands, unaudited)

 

     Three Months Ended
March 31,
 
     2014     2013  

Revenue

    

Public portal advertising and sponsorship

   $ 109,203      $ 93,438   

Private portal services

     24,629        19,324   
  

 

 

   

 

 

 
   $ 133,832      $ 112,762   
  

 

 

   

 

 

 

Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”) (a)

   $ 33,266      $ 21,289   

Interest, taxes, non-cash and other items (b)

    

Interest income

     15        21   

Interest expense

     (6,172     (5,832

Income tax provision

     (4,825     (226

Depreciation and amortization

     (7,328     (6,853

Non-cash stock-based compensation

     (8,690     (9,937
  

 

 

   

 

 

 

Net income (loss)

   $ 6,266      $ (1,538
  

 

 

   

 

 

 

 

(a) See Annex A-Explanation of Non-GAAP Financial Measures.
(b) Reconciliation of Adjusted EBITDA to net income (loss).


WEBMD HEALTH CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

 

     March 31, 2014      December 31, 2013  
     (unaudited)         

Assets

     

Cash and cash equivalents

   $ 778,401       $ 824,880   

Accounts receivable, net

     134,241         124,232   

Prepaid expenses and other current assets

     12,544         13,243   

Deferred tax assets

     13,588         13,620   
  

 

 

    

 

 

 

Total current assets

     938,774         975,975   

Property and equipment, net

     62,151         64,884   

Goodwill

     202,980         202,980   

Intangible assets, net

     13,266         13,834   

Deferred tax assets

     38,649         38,802   

Other assets

     28,144         29,153   
  

 

 

    

 

 

 

Total Assets

   $ 1,283,964       $ 1,325,628   
  

 

 

    

 

 

 

Liabilities and Stockholders’ Equity

     

Accrued expenses

   $ 54,910       $ 73,739   

Deferred revenue

     99,638         85,148   

Liabilities of discontinued operations

     1,506         1,506   
  

 

 

    

 

 

 

Total current liabilities

     156,054         160,393   

2.25% convertible notes due 2016

     252,232         252,232   

2.50% convertible notes due 2018

     400,000         400,000   

1.50% convertible notes due 2020

     300,000         300,000   

Other long-term liabilities

     21,673         22,103   

Stockholders’ equity

     154,005         190,900   
  

 

 

    

 

 

 

Total Liabilities and Stockholders’ Equity

   $ 1,283,964       $ 1,325,628   
  

 

 

    

 

 

 


WEBMD HEALTH CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)

 

     Three Months Ended
March 31,
 
     2014     2013  

Cash flows from operating activities:

    

Net income (loss)

   $ 6,266      $ (1,538

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

    

Depreciation and amortization

     7,328        6,853   

Non-cash interest, net

     1,128        1,082   

Non-cash stock-based compensation

     8,690        9,937   

Deferred income taxes

     201        (99

Changes in operating assets and liabilities:

    

Accounts receivable

     (10,009     4,809   

Prepaid expenses and other, net

     210        (193

Accrued expenses and other long-term liabilities

     (20,401     (14,850

Deferred revenue

     14,490        5,044   
  

 

 

   

 

 

 

Net cash provided by operating activities

     7,903        11,045   

Cash flows from investing activities:

    

Purchases of property and equipment

     (5,533     (2,876
  

 

 

   

 

 

 

Net cash used in investing activities

     (5,533     (2,876

Cash flows from financing activities:

    

Proceeds from exercise of stock options

     17,482        672   

Cash used for withholding taxes due on stock-based awards

     (5,326     (174

Purchases of treasury stock

     (65,052     (1,281

Excess tax benefit on stock-based awards

     4,047        —     
  

 

 

   

 

 

 

Net cash used in financing activities

     (48,849     (783
  

 

 

   

 

 

 

Net (decrease) increase in cash and cash equivalents

     (46,479     7,386   

Cash and cash equivalents at beginning of period

     824,880        991,835   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 778,401      $ 999,221